Subscribe

IDEAS / Tickers

TWST

Twist Bioscience

Verona Pharma’s Breakout Stood Out in a Weak Market

Patrick Dunuwila and Alfonso DePablos favored Verona’s relative strength on September 10, 2024, while separating bullish momentum from warning signs in Pennant, Check Point and Twist.

Recorded Stock Market TV Editorial

Ecolab’s Breakout and Three Other Charts Worth Watching

Steve Strazza and Patrick Dunuwila picked Ecolab as their favorite chart on July 11, 2024. Their review also set out distinct entry conditions for Twist Bioscience, Quanta Services and Denison Mines.

Recorded Stock Market TV Editorial

Search ideas